SECOND REGULAR SESSION
HOUSE BILL NO. 1586
102ND GENERAL ASSEMBLY
INTRODUCED BY REPRESENTATIVE CLEMENS.
3060H.01I DANARADEMANMILLER,ChiefClerk
AN ACT
To amend chapter 197, RSMo, by adding thereto one new section relating to multidose
medications given to patients at discharge.
Be it enacted by the General Assembly of the state of Missouri, as follows:
Section A. Chapter 197, RSMo, is amended by adding thereto one new section, to be
2 known as section 197.180, to read as follows:
197.180. 1. Medicationsinmultidosecontainersthatareadministeredtoorused
2 for a patient during the patient's hospital stay may, if so ordered by an authorized
3 health care provider, be sent with the patient at discharge to the patient's home or to
4 another health care facility.
5 2. Multidose medications shall include, but are not limited to, inhalers,
6 ointments, creams, medications requiring the original container for dispensing, insulin
7 pens and vials, eye drops, ear drops, wearable or on-body medication delivery systems,
8 and infusions that are currently connected to the patient's infusion device.
9 3. Multidose medications shall be labeled with the date, patient's name,
10 prescriber's name, name and address of the hospital, medication name and strength,
11 instructions for use, and other pertinent information. Labeling shall be performed by a
12 pharmacist, prescriber, or registered nurse. Labeled instructions for use may refer to
13 specificwritteninstructionsprovidedbyapharmacist,prescriber,orregisterednurseat
14 the time of discharge.
15 4. Controlled substances shall not be sent with the patient, except that wearable
16 oron-body medicationdeliverysystems ofcontrolledsubstancesorcontrolledsubstance
17 infusions currently connected to the patient's infusion device may be sent if:
EXPLANATION — Matter enclosed in bold-faced brackets [thus] in the above bill is not enacted and is
intended to be omitted from the law. Matter in bold-face type in the above bill is proposed language.
HB 1586 2
18 (1) The medication is necessary for administration during transport of the
19 patient;
20 (2) The quantity of the controlled substance sent is documented in the patient's
21 medical record by the person sending the medication; and
22 (3) The pharmacy is notified that the medication is being sent with the patient.
23 5. This section shall not require a class B hospital pharmacy to obtain or comply
24 with additional licensure or regulatory requirements.
✔